Magnitude Biosciences secures €1.5 million investment to scale its in vivo drug discovery platform. The funding, led by Northstar Ventures, will accelerate the commercialisation of VivoScan TM.
Amount Raised
€1.5 Million
Round Type
Seed
North East DistrictFinancial ServicesFinanceLendingBankingInvestors
Description
Magnitude Biosciences has secured €1.5 million in funding to enhance its VivoScan TM platform for drug discovery. The investment was led by Northstar Ventures and is aimed at commercializing their proprietary high-throughput screening technology. CEO Dr. Fozia Saleem expresses ambition to revolutionize drug discovery
Quick answer
Magnitude Biosciences raised €1.5 Million in a Seed round, dated September 15, 2026. Investors: Maven’s Regional Funds, New Angel Investors and Northstar Ventures. Magnitude Biosciences is based in North East District, Botswana.
- How much did Magnitude Biosciences raise?
- Magnitude Biosciences raised €1.5 Million in a Seed round on September 15, 2026.
- Who invested in Magnitude Biosciences?
- Maven’s Regional Funds, New Angel Investors and Northstar Ventures are named as investors in this round.
- Where is Magnitude Biosciences based and how big is it?
- Magnitude Biosciences is based in North East District, Botswana. Fundz records about 19 employees.
- Who are the decision-makers at Magnitude Biosciences?
- Fundz holds 1 contact at Magnitude Biosciences, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Financial Services and Finance around the same time
Companies in the same sectors as Magnitude Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Akme Fintrade (India) Limited raised $5.3M (Debt Financing) on October 26, 2026.
- VakıfBank raised $224M (Debt Financing) on October 23, 2026.
- ScribeUp raised $13M (Series A) on October 20, 2026.
- Medallion Financial raised $11M (Funding Round) on October 16, 2026.
- EFY Finance raised an undisclosed amount (Seed) on October 13, 2026.
- Cloud9 raised $500K (Pre-Seed) on October 7, 2026.
Who to call at Magnitude Biosciences, and when
A new round usually means Magnitude Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Magnitude Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Magnitude Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Magnitude Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Magnitude Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Magnitude Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.